|
|
|
|
|
By Ray Dogum, Chief Editor, Drug Discovery Online | The gold standard practice of conducting animal studies for evaluating toxicity, pharmacodynamics, and immunogenicity is being challenged by innovative alternatives – New Approach Methods (NAMs). | |
|
|
Formulation Development Of A JAK1 Inhibitor Extended-Release Tablet | By Dileep Boinipally, director of drug product formulation, Metsera | This scientific article presents a summary of the formulation development strategy of a JAK1 inhibitor extended-release tablet, with a focus on experimental design, data interpretation, and formulation decision-making. |
|
|
|
|
|
| Extractables And Leachables: Risk Management And Analytical Solutions | White Paper | By Matthew St. Lawrence, Todd Sprouse, M.S., and Erik Feldmann, Ph.D., Cambrex | Partnering with a CDMO that offers comprehensive and robust E&L studies can help facilitate a smooth product launch by ensuring minimal impact from impurities, all while mitigating risks. |
|
|
| Quantification And Qualification Of Adeno-Associated Virus | Poster | By Domenica Martorana, Jonathan Thorn, Mario Quinto, Anne Schieren, et al., QIAGEN | Discover how digital PCR enables precise, reproducible AAV quantification, overcoming qPCR limits with streamlined workflows and CGT-specific assays for safer gene therapy development. |
|
|
|
|
|
|
